【世界卫生组织-2025研报】INN Recommended List 94.pdfVIP

WHODrugInformation,Vol.39,No.3,2025RecommendedINN:List94

InternationalNonproprietaryNames

forPharmaceuticalSubstances(INN)

RECOMMENDEDInternationalNonproprietaryNames:List94

Noticeisherebygiventhat,inaccordancewithparagraph7oftheProcedurefortheSelectionof

RecommendedInternationalNonproprietaryNamesforPharmaceuticalSubstances[Off.Rec.WldHealth

Org.,1955,60,3(ResolutionEB15.R7);1969,173,10(ResolutionEB43.R9);ResolutionEB115.R4

(EB115/2005/REC/1)],thefollowingnamesareselectedasRecommendedInternationalNonproprietary

Names.TheinclusionofanameinthelistsofRecommendedInternationalNonproprietaryNamesdoes

notimplyanyrecommendationoftheuseofthesubstanceinmedicineorpharmacy.

ListsofProposed(1–117)andRecommended(1–78)InternationalNonproprietaryNamescanbefoundin

CumulativeListNo.17,2017(availableinCD-ROMonly).

DénominationscommunesinternationalesdesSubstancespharmaceutiques(DCI)

DénominationscommunesinternationalesRECOMMANDÉES:Liste94

Ilestnotifiéque,conformémentauxdispositionsduparagraphe7delaProcédureàsuivreenvuedu

choixdeDénominationscommunesinternationalesrecommandéespourlesSubstances

pharmaceutiques[

Actesoff.Org.mond.Santé,1955,60,3(résolutionEB15.R7);1969,173,10(résolution

EB43.R9);résolutionEB115.R4(EB115/2005/REC/1)]lesdénominationsci-dessoussontchoisiespar

l’OrganisationmondialedelaSantéentantquedénominationscommunesinternationales

recommandées.L’inclusiond’unedénominationdansleslistesdeDCIrecommandéesn’impliqueaucune

recommandationenvuedel’utilisationdelasubstancecorrespondanteenmédecine